ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2026
Arntl deficiency impairs NK cell function by reducing responsiveness to IL-15 and suppressing activation.
Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundNatural killer (NK) cells are crucial innate immune effectors with pivotal roles in tumor cytotoxicity and antiviral defense. Arntl (also known as Bmal1), a core circadian rhythm regulator, is essential for maintaining normal immune function; however, its specific regulatory impact on NK cells remains unclear. This study aimed to elucidate the mechanism by which Arntl governs NK cell functionality.
methodsConditional knockout of Arntl was induced in hematopoietic cells of mice. NK cell abundance, development, and effector functions were assessed in the spleen and bone marrow. Functional assays measured CD107a degranulation, IFN-γsecretion, target cell elimination (MHC-I-deficient cells), activation status, oxidative metabolism, and responsiveness to IL-15.
resultsThrough conditional knockout of Arntl in hematopoietic stem cells, we observed a significant reduction in NK cell within the spleen and bone marrow of mice, without impairing NK cell development. Functional assessments revealed that Arntl-deficient NK cells exhibited diminished CD107a degranulation, impaired IFN-γ secretion, and a markedly compromised ability to eliminate MHC-I-deficient target cells. Furthermore, Arntl-deficient NK cells displayed suppressed activation and reduced oxidative metabolism.
conclusionArntl is an important regulator of NK cell immunity. Its deficiency impairs NK cell effector functions by reducing responsiveness to IL-15, providing novel insights into the circadian control of anti-tumor and anti-viral responses.
Indexed as
Identifiers
42257758What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.